更强,更长,更好的阿片类药物对手? 纳尔梅芬不是纳洛的替代品
Alexander F Infante1, Abigail T Elmes1, Renee Petzel Gimbar1
1Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, 833 South Wood St (MC 886), Chicago, IL 60612, United States.
The International journal on drug policy
|January 17, 2024
概括
美国面临着由合成阿片类药物驱动的每日过量危机. 虽然批准了像纳尔梅芬这样的新型长效阿片类抗体,但目前的证据表明,与纳洛相比,它们可能不必要,可能会造成伤害.
科学领域:
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
- 公共卫生 公共卫生
背景情况:
- 美国正在经历一场严重的致命过量危机,每天有近200人死亡.
- 合成阿片类药物,特别是芬太尼,是主要的贡献者,涉及到2022年美国68%的过量死亡.
- 这场危机给社区,紧急服务和医疗保健系统带来了压力.
研究的目的:
- 探索引入长效阿片类药物抗剂的医疗需求和影响.
- 评估新药的潜在益处和风险,比如纳尔梅芬与当前的护理标准,纳洛.
主要方法:
- 对阿片类药物过量逆转药物的现有数据的审查.
- 与纳洛相比,纳尔梅芬的药理特性 (延长半衰期,更强的mu受体亲和力) 的分析.
- 探索新药的潜在临床影响.
主要成果:
- 纳洛是阿片类药物逆转治疗的既定,安全和有效的护理标准.
- 更强大,更长效的阿片类药物抗剂可能是不必要的,并可能导致不良影响.
- 潜在的危害包括更严重的戒断,困难的患者互动,以及启动阿片类药物使用障碍治疗的并发症.
结论:
- 现有的数据表明,纳洛仍然是首选的基于证据的,具有成本效益的治疗方法.
- 在采用比纳洛更强,更长效的阿片类抗体之前,需要更多的研究.
- 医疗保健专业人员应在使用较新的,更长效的药物时保持谨慎.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Opioid Analgesics: Morphine and Other Natural Cogeners
251
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
251
Opioid Receptors: Overview
847
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
847
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K


